Compare drug alternatives

Steglujan® Alternatives

Steglujan®(Ertugliflozin And Sitagliptin)
Soliqua®(Insulin Glargine And Lixisenatide)
Prescription Only
Steglujan is a medication that combines ertugliflozin and sitagliptin. These two components work together to manage blood sugar levels. Ertugliflozin helps the kidneys remove...
Prescription Only
Soliqua 100/33 is a combination medication featuring insulin glargine and lixisenatide. Insulin glargine offers prolonged blood glucose reduction, while lixisenatide enhances...
Dosage & AdministrationDosage & Administration comparison data
Administration
Dosing
Latin Shorthand
Financial AssistanceFinancial Assistance comparison data
Out-Of-Pocket Costs With Copay Card
Annual Cap
Assistance Expiration
Generics
No lower-cost generic available
No lower-cost generic available
Physician AdvisoryPhysician Advisory comparison data
Adverse Reactions
Most common adverse reactions associated with ertugliflozin (incidence ≥5%): female genital mycotic infections. Most common adverse reactions associated with sitagliptin (incidence ≥5%): upper respiratory tract infection, nasopharyngitis and headache. In the add-on to sulfonylurea and add-on to insulin studies, hypoglycemia was also more commonly reported in patients treated with sitagliptin compared to placebo.. Learn more.
The most common adverse reactions, reported in ≥5% of patients treated with SOLIQUA 100/33 include hypoglycemia, nausea, nasopharyngitis, diarrhea, upper respiratory tract infection, and headache.. Learn more.
Mechanism of Actions (MoA)
Special Populations
Popular Alternatives
    Relevant Resources
    Steglujan
    Soliqua
    Other indicationsCompare drug alternatives